1. Home
  2. TSN vs PODD Comparison

TSN vs PODD Comparison

Compare TSN & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyson Foods Inc.

TSN

Tyson Foods Inc.

HOLD

Current Price

$56.96

Market Cap

19.7B

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$304.01

Market Cap

22.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSN
PODD
Founded
1935
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7B
22.1B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
TSN
PODD
Price
$56.96
$304.01
Analyst Decision
Hold
Strong Buy
Analyst Count
10
19
Target Price
$61.70
$359.00
AVG Volume (30 Days)
3.7M
765.6K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
3.58%
N/A
EPS Growth
N/A
N/A
EPS
1.33
3.45
Revenue
$54,441,000,000.00
$2,521,800,000.00
Revenue This Year
$4.28
$32.55
Revenue Next Year
$0.76
$20.39
P/E Ratio
$42.87
$88.24
Revenue Growth
2.12
27.11
52 Week Low
$50.56
$230.05
52 Week High
$64.36
$354.88

Technical Indicators

Market Signals
Indicator
TSN
PODD
Relative Strength Index (RSI) 59.59 40.94
Support Level $52.65 $303.20
Resistance Level $58.67 $317.34
Average True Range (ATR) 1.27 13.12
MACD 0.14 -2.82
Stochastic Oscillator 69.93 3.14

Price Performance

Historical Comparison
TSN
PODD

About TSN Tyson Foods Inc.

Tyson Foods is a protein-focused food producer, selling raw chicken, beef, pork, and prepared foods. Chicken and beef are its two largest segments, each composing about one third of US sales. Prepared foods constituted 18% of fiscal 2024 sales and include brands like Tyson, Jimmy Dean, Hillshire Farm, Ball Park, and Sara Lee. However, most of these are in product categories rife with competition where Tyson does not have a massive market share lead. Tyson sells some products overseas, but the international segment accounts for just 4% of total revenue. The company is an active acquirer, with more recent years' purchases focused on international and food-service markets.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: